Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goals

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.